Pages
- 2016 CME4HD Agenda
- 2CARE
- About Clinical Trials
- About HSG
- Activate
- Activity
- All HSG Trials and Studies
- atest
- Care Education Videos
- Chair Job Description
- CME4HD
- CME4HD Agenda
- CME4HD Flyer
- CME4HD Invitation
- CME4HD Older Content
- CME4HD Online
- Co-Chair Job Description
- Contact
- Contact form test
- Contact Me About Future Research
- Coordinator Scholarship Form
- Credentialed Member Renewal
- CREST-E
- Current HSG Research Trials & Studies
- Disclaimer of Medical Advice
- Education
- Exhibitor Information
- Exhibitor Terms
- Explore Denver Scavenger Hunt
- Family Education Day Houston (older)
- Find an HSG Research Site
- First-HD ARC-HD
- Groups
- HD Care Improvement Project
- HD Drug Pipeline
- HD Insights Archive
- HD Insights Podcast
- HD Insights Vol. 13
- HD Insights Volume 14
- HD Insights Volume 15
- HD Insights Volume 16
- HD Insights: Volume 1
- HD Insights: Volume 10
- HD Insights: Volume 11
- HD Insights: Volume 12
- HD Insights: Volume 12
- HD Insights: Volume 13
- HD Insights: Volume 17
- HD Insights: Volume 2
- HD Insights: Volume 3
- HD Insights: Volume 4
- HD Insights: Volume 5
- HD Insights: Volume 6
- HD Insights: Volume 7
- HD Insights: Volume 8
- HD Insights: Volume 9
- HD Treatment and Educational Resources
- HD-NET
- HDCIP Partners
- Home
- HSG 2016 Agenda Overview
- HSG 2016 Feedback Survey
- HSG 2016 Feedback Survey Success
- HSG 2016 Funded List
- HSG 2016 Hotel Lodging Reimbursement Form
- HSG 2016 Registration
- HSG 2016 Registration
- HSG 2016 Registration Success
- HSG 2017 Abstract Lay Summaries
- HSG 2017 Agenda
- HSG 2017 Floor Plans
- HSG 2017 Funded List
- HSG 2017 HD Family Education Day Scholarship
- HSG 2017: Elevating HD
- HSG 2018 Agenda
- HSG 2018 Funded List
- HSG 2019 – Family Day
- HSG 2019: Navigating HD
- HSG 2020
- HSG Blog
- HSG Careers
- HSG COI Guidelines
- HSG Credentialed Sites
- HSG Family Education Day – 2018 HOUSTON
- HSG Family Education Day – Houston 2018
- HSG Site Intuitional Agreement
- HSG Travel Policy
- Huntington’s Disease Center of Excellence at USF
- I am the DIFFERENCE
- I am the DIFFERENCE stories
- Investigator Materials Uploads
- Join HSG
- KINECT-HD Study Locations
- Living with HD
- Managing Huntington disease in the 21st Century
- Maps 2
- Members
- Neurodegenerative Disorders Research
- new map test
- News
- Our Story
- Past HSG Research Trials & Studies
- Potential HSG Research Site Questionnaire
- Potential Site Coordinator Questionnaire
- Potential Site Investigator Questionnaire
- Pride-HD
- Privacy Statement
- PROOF-HD
- PROOF-HD FAQ
- PROOF-HD Study Locations
- PROOF-HD-AL
- PROOF-HD-ES
- PROOF-HD-IT
- PROOF-HD-PL
- Register
- Seed Fund Projects
- SIGNAL TEST
- Site Coordinator Materials Upload
- Sitemap
- Sponsor The HSG Annual Meeting
- Sponsorship code backup
- Subscribe to HD Insights
- Support Us
- Survey
- Terms of Use
- Tools + Resources
- UHDRS Symposium lodging request
Posts by category
- Category: Blog
- Huntington Study Group Announces A Partnership with Prilenia Therapeutics to Conduct A Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease
- Huntington Study Group Launches New CME Accredited Interactive Case Study Courses
- HSG Announces Virtual Annual Meeting in 2020
- Publication of Clinical Guidelines for Physical Therapy in Huntington Disease
- Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease
- Huntington Study Group Spotlighted on Rochester, NY Television
- Huntington Study Group Achieves 100th Credentialed Research Site Milestone
- The Huntington Study Group Announces New Education Committees
- HSG Announces Location for 2019 Annual Meeting
- HD Insights – Autumn Issue
- Dr. Nicolò Zarotti Named Recipient of the Peter Como Scholarship
- HSG Scholarship Winners Receive Funding to Attend Premier Huntington’s Disease Conference
- Huntington Study Group Welcomes New Leadership May 1
- New HD Insights Is Out (Vol. 19)
- Career Opportunity: Clinical Fellowship in Huntington Disease Research at UBC
- HSG Leadership Election Results
- 2018 HSG Election
- Ionis and Roche announce promising news on the Ionis-HTTRx trial
- Loss of our friend, Dr. Kimberly Quaid de Cordon
- Welcome new staff member, members of leadership team
- We need you!
- Seeking Survey Participants
- World Experts in HD to Convene in Nashville
- Registration for HSG 2016 is now open
- JAMA publishes results of First-HD trial
- Vaccinex Receives FDA Fast Track Designation for VX15 Antibody for the Treatment of Huntington’s Disease
- What is HSG?
- HSG adds board member Joni Steinman
- Sleep disturbances are among the earliest non-motor symptoms in HD
- HSG 2016: Call for Abstracts
- Opportunity for fellowship in Regulatory Science
- FDA wants to hear from you!
- Why participating in clinical trials is important to Katie
- Continuing education opportunity in Tampa, FL
- Life Interrupted
- What HSG Means to Jenna
- What HSG Means to Martha
- What HSG Means to Julie
- What HSG Means to Claudia
- Category: Events
- HSG 2015 Evening Blog: Enroll-HD
- Regional Health Care Practitioners Invited to Learn More about Huntington Disease Oct. 23
- LATE-BREAKING: More Scholarships Available for HSG 2015
- HSG 2015 HD Family Education Day
- Registration is open for HSG 2015: Building Our Future
- CLOSED: Call for Abstracts: 9th Annual HD Clinical Research Symposium
- Apply for a New Member Scholarship
- Apply to be a Shoulson Scholar
- An Interview with Dr. Nancy Wexler: Discovering the Huntington Disease Gene
- Category: HSG 2016
- Category: HD Insights
- HD Insights Volume 17 (PDF)
- FDA approves deutetrabenazine (AUSTEDO™) to treat chorea
- Meet the Scientist : Beverly Davidson
- Game-changing gene-silencing therapies for HD
- Research Round-Up
- Highlights of CHDI
- HD Research Around the World: Brazil
- Highlights from the Journal of HD
- Editor’s Letter
- HD Insights Volume 16 (PDF)
- 2016: Advances and Challenges in HD Therapeutic Development
- Brief report: Pfizer Amaryllis trial ends: negative results lead to termination of extension study
- Highly Cited HD Research
- Research Round-Up
- MEET THE COMPANY: uniQure
- MEET THE SCIENTIST: Pavlina Konstantinova, MSc, PhD
- MEET THE COMPOUND: AMT-130
- Highlights from the Journal of HD
- Thank you to Teva Pharmaceuticals
- Highlights of HSG 2016: Discovering Our Future
- Thank you to Raptor
- Editor’s Letter
- Job Opportunity: Deputy Editor, HD Insights
- HD Insights Volume 15 (PDF)
- Finding balance in HD: The role of PIAS1 in protein homeostasis
- Meet the Company: WAVE Life Sciences
- Meet the Compounds: WVE-120101 and WVE-120102
- Highlights from the Journal of Huntington’s Disease
- Research Round-Up: Insights of the Year 2015-2016
- Career Opportunity: Vice President, Global Specialty Development, NDD, Teva
- Career Opportunity: Director/Sr. Director Global Specialty Development, Neurodegenerative Diseases, Teva
- Meet the Next Generation
- Editor’s Letter
- HD Insights Volume 14 (PDF)
- Meet the Investigator: Diana Rosas
- Research Round-Up
- Lifestyle and HD Management
- Meet the Funder
- Prion-like protein spread in neurodegenerative diseases of the CNS and development of therapeutic approaches
- Highlights from the Journal of Huntington’s Disease
- Highlights of CHDI
- Editor’s Letter
- HD Insights Volume 13 (PDF)
- Highlights of HSG 2015
- Genetic factors that modify clinical onset of HD
- Meet the Partner
- Antisense Oligonucleotides Enter Clinical Trials
- Research Round-Up
- Highly Cited HD Research
- Editor’s Letter
- HD Insights Volume 12 (PDF)
- Meet the Next Generation
- HD Highlights: 19th International Congress of Parkinson’s Disease and Movement Disorders
- Meet the Compound: VX15/2503
- Meet the CEO: Maurice Zauderer, PhD
- Editor’s Letter
- Research Round-Up: Insights of the Year 2014-15
- HD Insights Volume 11 (PDF)
- Meet the Attorney
- Research Round-Up
- Editor’s Letter
- Update on HD Disease-Modifying Strategies on the Horizon
- Unraveling the Cause of Dysfunctional Autophagy in HD
- Teva acquires Auspex for $3.5 billion
- Greasing the Huntington Disease Brain: Palmitoylation as a therapeutic target
- Highlights from the 10th Annual HD Therapeutics Conference
- HD Insights Volume 10 (PDF)
- Editor’s Letter
- Research Round-Up
- First-HD Results Released
- Meet the Investigator
- Highlights of HSG 2014
- Meet the Compound: Laquinimod
- Research Round-Up: Insights of the Year 2013-2014 (In the Clinic)
- Meet the CEO
- Meet the Founder
- Meet the Compound: RP103 (cysteamine bitartrate delayed-release)
- Editor’s Letter
- Research Round-Up: Insights of the Year 2013-2014 (In the Lab)
- Meet the Company
- Highlights from the EHDN 2014 Plenary Meeting
- Research Round-Up: Insights of the Year 2013-2014 (In Imaging and Biomarkers)
- Meet the Compound: Olesoxime (TRO19622)
- Research Round-Up
- Editor’s Letter
- Repair-HD
- HD Highlights of the 18th International Congress of Parkinson’s Disease and Movement Disorders
- Largest HD Clinical Trial Halted
- Meet the Investigator
- Animal Models of HD
- HD Insights Volume 9 (PDF)
- HD Insights Volume 7 (PDF)
- Meet the Investigator
- PREDICTions: Using High-Performance Computing to Visualize the HD Brain
- Meet the CEO
- Editor’s Letter
- Research Round-Up
- Prana Releases Promising Results
- Meet the Company
- HD Research around the World: Canada
- Meet the Compound: SD-809 (dutetrabenazine)
- Highlights from the Huntington Study Group 2013 Annual Meeting and Clinical Research Symposium
- Meet the Compound: Coenzyme Q10
- Research Round-Up
- Highlights from the 2013 World Congress on Huntington’s Disease
- Selected by Chance: An Interview with Ralf Reilmann
- Editor’s Letter
- HD Research Around the World: France
- HD Insights Volume 5 (PDF)
- HD Insights Volume 8 (PDF)
- HD Research Around the World: Australia
- Meet the Company
- Part of the Solution: An Interview with Rodrigo Osorio
- Meet the Compound: PF-02545920
- Meet the Investigator
- Research Round-Up
- Editor’s Letter
- HD Insights Volume 4 (PDF)
- Editor’s Letter
- HD Research Around the World: Japan
- Research Round-Up
- Lundbeck: Building Hope for HD with Casa De Hogar
- Meet the Compound: Huntexil
- Meet the Investigator
- Meet the Company
- HD Insights Volume 6 (PDF)
- HD Insights Volume 3 (PDF)
- Meet the Company
- Research Around the World: Chile
- Highlights from the CHDI HD Therapeutics Conference
- The Use of Antisense Oligonucleotides for Gene Silencing
- Research Round-Up
- HD Insights Volume 2 (PDF)
- Meet the Journal
- Highlights from the 2011 Huntington Study Group Meeting
- Research Round-Up
- Inside the NINDS with Dr. Walter Koroshetz
- HD Insights Volume 1 (PDF)
- How Many People Have Huntington Disease?
- Highlights from the World Congress on HD
- Meet the Company
- Research Round-Up
- Meet the Investigator
- Editor’s Welcome
- Category: HSG 2015
- Category: I am the DIFFERENCE
- Help4HD Blog Radio features I am the DIFFERENCE campaign
- Lauren Holder: I am the DIFFERENCE
- Katrina Hamel: I am the DIFFERENCE
- Katie Jackson: I am the DIFFERENCE
- Chris O’Brien: I am the DIFFERENCE
- Cory Sargent: I am the DIFFERENCE
- Rusty and Theresa: I am the DIFFERENCE
- Ann and David Nelson: I am the DIFFERENCE
- Category: News
- HSG Announces Launch of CME4HD 2019 – Accredited Online Education Platform
- Overnight Switch from Tetrabenazine to Deutetrabenazine Safe, Trial Shows
- FDA Approves Second Drug for Huntington Disease Symptom
- Chorea Reduced by Deutetrabenazine in Study led by HSG
- FDA Requests More Data on Potential New Treatment for Huntington Disease
- Show off your credentials
- SIGNAL completes enrollment in cohort A
- Category: Press Releases
- Announcing HSG’s 2015 Award Winners
- Teva Press Release: April 24, 2014
- Teva & Active Biotech Press Release: November 4, 2014
- Auspex Press Release: December 16, 2014
- HSG Press Release: October, 2014
- HSG Press Release: August 8, 2014
- HSG Press Release: September 2012
- HSG Press Release: May 14, 2009
- HSG Press Release: December 2, 2008
CM Tooltip Glossary
- Antibody
- Non-Physician Policy
- Zinc-finger Nucleases
- YAC
- YAC128
- Vesicle
- Ventricle
- Vascular System
- Uterus
- Trinucleotide Repeat
- Transgenic
- Transcriptional Regulation
- Transcriptional Dysregulation
- Transcription Factor
- Transcription
- Transcranial Magnetic Stimulation
- TR-FRET
- Total Functional Capacity
- Therapeutics
- Synapse
- Synaptophysin
- Synaptic transmission
- Suprachiasmatic Nucleus
- Stem Cells
- Statistically Significant
- Splicing
- Spinocerebellar Ataxia
- Soma
- Sodium
- siRNA
- Single Nucleotide Polymorphisms
- Significance Testing
- Sense Strand
- SCA
- SBMA
- SAHA
- Ryanodine Receptor
- Ro 61-8048
- RNA Interference
- RNA
- Ribosome
- Rhes
- Reduced Penetrance Allele
- Recombinant
- Receptor
- Rabies
- R6/2
- Quinolinic Acid
- Putamen
- Pluripotency
- Primate
- Promoter
- Prion
- Prevalence
- Prenatal Testing
- Pre-implantation Genetic Diagnosis
- Post-translational Modification
- PolyQ
- Polymerase Chain Reaction
- Placenta
- Placebo
- Pineal
- Phosphodiesterase
- Phosphatase
- Phenylbutyrate
- Phase III
- Perseveration
- Peptides
- PDE10
- Parkinson's Disease
- PACSIN
- Open Label
- Observational
- Nucleus
- Nucleotide Bases
- Non-disclosure
- Neutron
- Neuroprotection
- Neuron
- Neurodegenerative
- N-Terminal Fragment
- multiple sclerosis
- Motor Neuron Disease
- Mitochondria
- Microglia
- Microdialysis
- methionine
- metabolism
- meta-analysis
- messenger RNA
- Mesenchmal
- Melatonin
- medium spiny neuronmedium spiny neurons
- magnetic resonance
- longitudinal study
- leptin
- kynurenine
- kynurenic acid
- knockout
- knock-in
- KMO
- kinase
- juvenile HD
- JM6
- intracranial volume
- interventional
- intermediate alleles
- intermediate allele
- insulin
- inflammation
- induced pluripotent stem cells
- In vitro fertilization
- hypothalamus
- Hydrophobic
- Hydrophilic
- huntingtin protein
- HTTAS
- HTT
- hormone
- histone
- hippocampus
- heat shock response
- HDAC
- growth factor
- glutamine
- glutamate
- Genome Editing
- genome
- genetic engineering
- gene silencing
- GDNF
- Ganglioside
- GABA
- frontotemporal dementia
- fetus
- expression profiling
- exosome
- exclusion testing
- excitotoxic
- ependymal cells
- enteric nervous system
- Endoplasmic Reticulum
- embryo
- efficacy
- dystonia
- dopamine
- DNA fingerprinting
- differentiate
- dendritic cell
- deep brain stimulation
- cytoplasm
- cytokine
- Cyclic-GMP
- Cyclic-AMP
- CSF
- cross-sectional study
- cohort
- coenzyme-Q10
- circadian
- cilia
- chromosomes
- chorionic villus sampling
- Chaperone
- Cervix
- CED
- Caspase inhibitor
- Caffeine
- Bone marrow
- Blood-brain barrier
- Biomarker
- BDNF
- BACHD
- BACE1
- BAC
- Axon
- ASOs
- Apoptosis
- Antioxidant
- Anti-sense
- Amyloid
- Amygdala
- Amino acid
- Alpha-1 (also known as alpha-1-antitrypsin)
- Allele
- aggregate (also known as aggregates)
- Acetyl
- AAV
- Symptomatic
- Recessive
- Presymptomatic
- Personality changes
- Psychiatric disturbances
- Neurodegenerative
- Hereditary
- Genetic testing
- Dominant
- Dementia
- Chorea
- CAG Repeat
- Anticipation
- At-risk